Education
About Us
Working with TipRanks
Follow Us
Tengion (TNGNQ)
:TNGNQ
Autologous Neobladder Construct
Overactive Bladder
Phase II
Withdrawn
Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence
Jan 03, 2008
―
Autologous Neobladder Construct
Neurogenic Bladder
Phase II
Terminated
Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury
Aug 03, 2007
―
Autologous Neo Bladder Construct
Neurogenic Bladder
Phase II
Terminated
Augmentation Cystoplasty Using an Autologous Neo-Bladder
Jan 04, 2007
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tengion (TNGNQ) have in its pipeline
TNGNQ is currently developing the following drugs: Autologous Neobladder Construct, Autologous Neobladder Construct, Autologous Neo Bladder Construct. These drug candidates are in various stages of clinical development as the company works toward FDA approval.